Trial Profile
A Phase II Protocol in Borderline Resectable Pancreatic Cancer Using Gemcitabine/Docetaxel Chemotherapy and An Oxaliplatin-Based Chemoradiation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 May 2010
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Fluorouracil (Primary) ; Gemcitabine (Primary) ; Interferon alpha (Primary) ; Oxaliplatin (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 25 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 25 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2008 New trial record.